{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:40Z","timestamp":1740149860425,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12328-024-02022-w","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T17:25:02Z","timestamp":1722446702000},"page":"910-914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biologic therapy for ulcerative colitis associated with immune thrombocytopenia"],"prefix":"10.1007","volume":"17","author":[{"given":"Manabu","family":"Nagayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Oguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Owada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy Scott","family":"Longman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3601-1153","authenticated-orcid":false,"given":"Hironori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"2022_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389:1756\u201370.","journal-title":"Lancet"},{"key":"2022_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ajg.2010.343","volume":"106","author":"SR Vavricka","year":"2011","unstructured":"Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110\u20139.","journal-title":"Am J Gastroenterol"},{"key":"2022_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ecco-jcc\/jjac179","volume":"17","author":"H Mahajna","year":"2023","unstructured":"Mahajna H, Verstockt B, Bergemalm D, et al. Idiopathic thrombocytopaenic purpura associated with inflammatory bowel disease: a multicentre ECCO CONFER case series. J Crohns Colitis. 2023;17:722\u20137.","journal-title":"J Crohns Colitis"},{"key":"2022_CR4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625\u20139.","journal-title":"N Engl J Med"},{"key":"2022_CR5","doi-asserted-by":"publisher","DOI":"10.3402\/jchimp.v4.23386","author":"S Chandra","year":"2014","unstructured":"Chandra S, Finn S, Obah E. Immune thrombocytopenic purpura in ulcerative colitis: a case report and systematic review. J Community Hosp Intern Med Perspect. 2014. https:\/\/doi.org\/10.3402\/jchimp.v4.23386.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"2022_CR6","first-page":"582","volume":"33","author":"LM Higuchi","year":"2001","unstructured":"Higuchi LM, Joffe S, Neufeld EJ, et al. Inflammatory bowel disease associated with immune thrombocytopenic purpura in children. J Pediatr Gastroenterol Nutr. 2001;33:582\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2022_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1442-200X.2010.03308.x","volume":"53","author":"M Funato","year":"2011","unstructured":"Funato M, Fukao T, Sasai H, et al. Successful treatment of pediatric immune thrombocytopenic purpura associated with ulcerative colitis. Pediatr Int. 2011;53:771\u20133.","journal-title":"Pediatr Int"},{"key":"2022_CR8","first-page":"1055","volume":"105","author":"M Kawakubo","year":"2008","unstructured":"Kawakubo M, Tokunaga T, Kobari S, et al. A case of ulcerative colitis with preexisting idiopathic thrombocytopenic purpura. Nihon Shokakibyo Gakkai Zasshi. 2008;105:1055\u201360.","journal-title":"Nihon Shokakibyo Gakkai Zasshi."},{"key":"2022_CR9","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829\u201366.","journal-title":"Blood Adv"},{"key":"2022_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12185-019-02790-z","volume":"111","author":"H Kashiwagi","year":"2020","unstructured":"Kashiwagi H, Kuwana M, Hato T, et al. Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision. Int J Hematol. 2020;111:329\u201351.","journal-title":"Int J Hematol"},{"key":"2022_CR11","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","volume":"158","author":"JD Feuerstein","year":"2020","unstructured":"Feuerstein JD, Isaacs KL, Schneider Y, et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158:1450\u201361.","journal-title":"Gastroenterology"},{"key":"2022_CR12","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2169\/internalmedicine.56.7909","volume":"56","author":"T Iwasa","year":"2017","unstructured":"Iwasa T, Nakamura K, Ihara E, et al. The effective treatment with cyclosporine of a ulcerative colitis patient with concurrent idiopathic thrombocytopenic purpura who subsequently developed spontaneous pneumomediastinum. Intern Med. 2017;56:1331\u20137.","journal-title":"Intern Med"},{"key":"2022_CR13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2169\/internalmedicine.52.8856","volume":"52","author":"T Etou","year":"2013","unstructured":"Etou T, Iizuka M, Ohshima A, et al. Ulcerative colitis accompanied by idiopathic thrombocytopenic purpura and Helicobacter pylori infection. Intern Med. 2013;52:547\u20139.","journal-title":"Intern Med"},{"key":"2022_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1046\/j.1365-2141.2002.03612.x","volume":"118","author":"K Kohda","year":"2002","unstructured":"Kohda K, Kuga T, Kogawa K, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol. 2002;118:584\u20138.","journal-title":"Br J Haematol"},{"key":"2022_CR15","first-page":"1073","volume":"117","author":"Y Kawamoto","year":"2020","unstructured":"Kawamoto Y, Sakakibara Y, Ishida H, et al. A case of idiopathic thrombocytopenic purpura development after total colectomy for ulcerative colitis. Nihon Shokakibyo Gakkai Zasshi. 2020;117:1073\u201380.","journal-title":"Nihon Shokakibyo Gakkai Zasshi."},{"key":"2022_CR16","doi-asserted-by":"publisher","first-page":"136","DOI":"10.11641\/pde.68.2_136","volume":"68","author":"S Ono","year":"2006","unstructured":"Ono S, Kamoshida T, Ochiai T, et al. A case of ulcerative colitis with idiopathic thrombocytopenic purpura. Prog Dig Endosc. 2006;68:136\u20137.","journal-title":"Prog Dig Endosc"},{"key":"2022_CR17","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.3919\/jjsa.67.1824","volume":"67","author":"M Miyamoto","year":"2006","unstructured":"Miyamoto M, Kono T, Onuma S, et al. A case of ulcerative colitis with idiopathic thrombocytopenic purpura. Nihon Rinsho Geka Gakkai Zasshi. 2006;67:1824\u20137.","journal-title":"Nihon Rinsho Geka Gakkai Zasshi"},{"key":"2022_CR18","first-page":"953","volume":"36","author":"N Ozawa","year":"2016","unstructured":"Ozawa N, Tomizawa N. A case of idiopathic thrombocytopenic purpura with ulcerative colitis. J Abdom Emerg Med. 2016;36:953\u20136.","journal-title":"J Abdom Emerg Med"},{"key":"2022_CR19","first-page":"226","volume":"47","author":"K Queliza","year":"2017","unstructured":"Queliza K, Ihekweazu FD, Ali A, et al. Inflammatory bowel disease and immune thrombocytopenic purpura: combined immune dysregulation in an adolescent. Ann Clin Lab Sci. 2017;47:226\u20138.","journal-title":"Ann Clin Lab Sci"},{"key":"2022_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/ibd.21327","volume":"17","author":"WGN Mares","year":"2011","unstructured":"Mares WGN, Gerver J, Masclee AAM, et al. Anti-TNF treatment of ulcerative colitis associated with idiopathic thrombocytopenic purpura. Inflamm Bowel Dis. 2011;17:864\u20135.","journal-title":"Inflamm Bowel Dis"},{"key":"2022_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117704","volume":"10","author":"X Ye","year":"2015","unstructured":"Ye X, Zhang L, Wang H, et al. The role of IL-23\/Th17 pathway in patients with primary immune thrombocytopenia. PLoS ONE. 2015;10: e0117704.","journal-title":"PLoS ONE"},{"key":"2022_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3109\/09537104.2014.934217","volume":"26","author":"Q Li","year":"2015","unstructured":"Li Q, Yang M, Xia R, et al. Elevated expression of IL-12 and IL-23 in patients with primary immune thrombocytopenia. Platelets. 2015;26:453\u20138.","journal-title":"Platelets"},{"key":"2022_CR23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.dld.2018.06.008","volume":"50","author":"S Renna","year":"2018","unstructured":"Renna S, Mocciaro F, Ventimiglia M, et al. A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis. Dig Liver Dis. 2018;50:1292\u20138.","journal-title":"Dig Liver Dis"},{"key":"2022_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.873607","volume":"13","author":"N Garabatos","year":"2022","unstructured":"Garabatos N, Santamaria P. Gut microbial antigenic mimicry in autoimmunity. Front Immunol. 2022;13: 873607.","journal-title":"Front Immunol"},{"key":"2022_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.coi.2005.09.004","volume":"17","author":"N Yuki","year":"2005","unstructured":"Yuki N. Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr Opin Immunol. 2005;17:577\u201382.","journal-title":"Curr Opin Immunol"},{"key":"2022_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10112139","author":"N Latov","year":"2022","unstructured":"Latov N. Campylobacter jejuni infection, anti-ganglioside antibodies, and neuropathy. Microorganisms. 2022. https:\/\/doi.org\/10.3390\/microorganisms10112139.","journal-title":"Microorganisms"},{"key":"2022_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1128\/iai.61.1.303-306.1993","volume":"61","author":"HL Klaasen","year":"1993","unstructured":"Klaasen HL, Van der Heijden PJ, Stok W, et al. Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect Immun. 1993;61:303\u20136.","journal-title":"Infect Immun"},{"key":"2022_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12189","volume":"260","author":"C Gutzeit","year":"2014","unstructured":"Gutzeit C, Magri G, Cerutti A. Intestinal IgA production and its role in host-microbe interaction. Immunol Rev. 2014;260:76\u201385.","journal-title":"Immunol Rev"},{"key":"2022_CR29","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.immuni.2019.02.006","volume":"50","author":"T Castro-Dopico","year":"2019","unstructured":"Castro-Dopico T, Dennison TW, Ferdinand JR, et al. Anti-commensal IgG drives intestinal inflammation and type 17 immunity in ulcerative colitis. Immunity. 2019;50:1099-1114.e10.","journal-title":"Immunity"},{"key":"2022_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41591-022-01680-y","volume":"28","author":"M Uzzan","year":"2022","unstructured":"Uzzan M, Martin JC, Mesin L, et al. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. Nat Med. 2022;28:766\u201379.","journal-title":"Nat Med"},{"key":"2022_CR31","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1136\/gutjnl-2012-303063","volume":"62","author":"M Uo","year":"2013","unstructured":"Uo M, Hisamatsu T, Miyoshi J, et al. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through Fc\u03b3R-mediated CD14 macrophage activation. Gut. 2013;62:1734\u201344.","journal-title":"Gut"},{"key":"2022_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","volume":"166","author":"A Gilliland","year":"2024","unstructured":"Gilliland A, Chan JJ, De Wolfe TJ, et al. Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care. Gastroenterology. 2024;166:44\u201358.","journal-title":"Gastroenterology"},{"key":"2022_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bjh.18773","volume":"203","author":"A Roeser","year":"2023","unstructured":"Roeser A, Lazarus AH, Mah\u00e9vas M. B cells and antibodies in refractory immune thrombocytopenia. Br J Haematol. 2023;203:43\u201353.","journal-title":"Br J Haematol"},{"key":"2022_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.thromres.2020.03.012","volume":"190","author":"C Liu","year":"2020","unstructured":"Liu C, Cheng L, Ji L, et al. Intestinal microbiota dysbiosis play a role in pathogenesis of patients with primary immune thrombocytopenia. Thromb Res. 2020;190:11\u20139.","journal-title":"Thromb Res"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02022-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02022-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02022-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T13:19:31Z","timestamp":1727443171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02022-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02022-w","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H. Yamamoto has received honoraria, grants, and royalties from the Fujifilm Corporation. He has also received honoraria from Takeda Pharmaceutical Company, Janssen Pharmaceutical, Mitsubishi Tanabe Pharma Corporation, and AbbVie Inc. R. Longman is a board member of Pfizer, BMS, and CJ Bioscience and received a research grant from Boehringer Ingelheim. T. Yano received honoraria from Otsuka Pharmaceutical factory and Takeda Pharmaceutical Company. H. Sakamoto received a research grant from Fujifilm Corporation and an endowed chair from FUJIFILM Medical Co. Ltd. The other authors disclose no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008(5).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from all the patients to be included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}